Ocrevus, also known by its generic name ocrelizumab, is a monoclonal antibody used for certain forms of multiple sclerosis. It is administered through intravenous infusion, meaning the medicine enters the bloodstream through a vein. Because infusion reactions can occur, healthcare professionals typically monitor patients during treatment and for a period afterward.
The type and severity of side effects can vary between individuals. Some effects are mild and temporary, while others may require prompt medical assessment. Understanding the possible reactions can help people recognize changes and discuss them appropriately with their healthcare team.
Side effects associated with Ocrevus may occur during treatment or at other times. Infusion reactions are particularly important because they can develop during the infusion or within the period following treatment.
Commonly reported effects may include:
Infusion reactions can range from mild to more serious. Healthcare professionals may adjust or temporarily stop an infusion if a reaction occurs and provide appropriate treatment based on the symptoms. Medicines may also be given before an infusion to reduce the likelihood or severity of certain reactions.
Some symptoms require immediate attention because they may indicate a more serious reaction. Severe breathing difficulties, swelling of the face or throat, significant dizziness, fainting, or widespread allergic symptoms should be reported to medical professionals promptly.
Important considerations include:
The risk of side effects can depend on individual health factors, other medicines, and previous reactions. Anyone receiving Ocrevus should follow the monitoring and follow up recommendations provided by their healthcare professional.
Ocrevus side effects and infusion reactions can vary considerably from person to person. Learning about common symptoms and recognizing signs that may require medical attention can support informed communication with healthcare professionals. This article is provided for general informational and educational purposes only and does not provide medical diagnosis, treatment, sales, or healthcare services. Individuals receiving Ocrevus should discuss personal concerns, symptoms, and treatment decisions with a qualified healthcare professional.